Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jan;19(1):285-295.
doi: 10.1002/alz.12630. Epub 2022 Apr 2.

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Affiliations
Randomized Controlled Trial

Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial

Agnetha D Fruijtier et al. Alzheimers Dement. 2023 Jan.

Abstract

Introduction: Empirical studies on effective communication for amyloid disclosure in mild cognitive impairment (MCI) are lacking. We aimed to study the impact of six communication strategies.

Method: We performed a randomized controlled trial with seven randomly assigned, video-vignette conditions: six emphasizing a communication strategy and one basic condition. All showed a scripted consultation of a neurologist disclosing positive amyloid positron emission tomography (PET) scan results to an MCI patient. Healthy individuals (N = 1017; mean age ± SD 64 ± 8, 808 (79%) female) were instructed to imagine themselves in the video, answered questionnaires assessing information recall, emotional state, and behavioral intentions, and evaluate the physician/information.

Results: "Risk best practice" resulted in highest free recall compared to other strategies (P < .05), except "emotional support". Recall in "emotional support" was better compared to "basic-' and elaborate information"(P < .05). "Risk best practice" resulted in the highest uncertainty (P < .001). "Teach-back" and "emotional support" contributed to the highest evaluations (P -values < .01).

Conclusion: Risk communication best practices, attending to emotions, and teach-back techniques enhance information recall of amyloid-PET results, and could contribute to positive care evaluations.

Keywords: MCI; amyloid status; communication; disclosure; mild cognitive impairment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic overview of study measures
FIGURE 2
FIGURE 2
Boxplots present significant differences between communication strategies on free information recall, and information recognition. Analyses of variance (ANOVAs) showed an effect of condition on both free information recall and information recognition. Post hoc Bonferroni adjusted comparisons between conditions showed highest free information recall in the risk‐best practice condition, and highest information recognition in the emotional support condition. * P < .05, ** P < .01, P < .001
FIGURE 3
FIGURE 3
Boxplots present significant differences between communication strategies on outcome measures uncertainty, trust, satisfaction with physician, and information satisfaction. Analysis of variance (ANOVA) showed an effect of conditions for uncertainty, trust in the physician, satisfaction with the physician, and satisfaction with the information. Post hoc Bonferroni adjusted comparisons between conditions showed highest uncertainty in the risk‐best practice condition, highest trust in‐ and satisfaction with the physician, and the information in the teach‐back condition. * P < .05, ** P < .01, P < .001

References

    1. Dubois B, Padovani A, Scheltens P, Rossi A, Dell'Agnello G. Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges. J Alzheimers Dis. 2016;49:617–631. - PMC - PubMed
    1. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279. - PMC - PubMed
    1. van Maurik IS, Zwan MD, Tijms BMet al. Interpreting biomarker results in individual patients with mild cognitive impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) project. JAMA Neurol. 2017;74:1481–1491. - PMC - PubMed
    1. Kunneman M, Pel‐Littel R, Bouwman FH, et al. Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: the ABIDE project. Alzheimers Dement (N Y). 2017;3:314–322. - PMC - PubMed
    1. Grill JD, Apostolova LG, Bullain S, et al. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017;9:35. - PMC - PubMed

Publication types